Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Acthar Gel in Participants With Pulmonary Sarcoidosis

ClinicalTrials.gov ID: NCT03320070

Public ClinicalTrials.gov record NCT03320070. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double Blind, Placebo Controlled Exploratory Study to Assess the Efficacy and Safety of Acthar Gel in Subjects With Pulmonary Sarcoidosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to find out if Acthar Gel is safe and effective to treat pulmonary sarcoidosis. Participants will be randomly assigned (like flipping a coin) to receive a shot under their skin of Acthar Gel or a matching placebo gel that has no drug in it. They will receive their assigned shot twice a week for 24 weeks. All participants who complete the 24-week treatment period will be eligible to receive Acthar Gel for 24 more weeks, even if they were originally in the placebo group.

Study identification

NCT ID
NCT03320070
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Mallinckrodt
Industry
Enrollment
55 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 21, 2018 (Actual)
Primary completion
Nov 15, 2021 (Actual)
Completion
Nov 15, 2021 (Actual)
Last update posted
Feb 27, 2023

2018 – 2021

United States locations

U.S. sites
29
U.S. states
16
U.S. cities
29
Facility City State ZIP Site status
UAB Lung Health Center Birmingham Alabama 35294 —
David Geffen School of Medicine Los Angeles California 90095 —
National Jewish Health Denver Colorado 80206 —
University of Florida Division of Pulmonary, Critical Care, and Sleep Medicine Gainesville Florida 32610 —
University of Miami Miller School of Medicine Miami Florida 33125 —
Central Florida Pulmonary Group PA Orlando Florida 32803 —
Rush University Medical Center Chicago Illinois 60612 —
Laporte County Institute For Clinical Research Michigan City Indiana 46360 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Howard County Center for Lung and Sleep Medicine, LLC Columbia Maryland 21044 —
Washington University School of Medicine St Louis Missouri 63110 —
Valley Medical Group Ridgewood New Jersey 07450 —
Albany Medical Center Albany New York 12208 —
American Health Research Inc Charlotte North Carolina 28207 —
Duke University Medical Center Durham North Carolina 27710 —
Clinical Research of Gastonia Gastonia North Carolina 28054 —
University of Cincinnati Medical Center Cincinnati Ohio 45267 —
Cleveland Clinic Cleveland Ohio 44195 —
Penn State Milton S Hershey Medical Center Hershey Pennsylvania 17033 —
Temple Lung Center Philadelphia Pennsylvania 19140 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Berks Schuylkill Respiratory Specialists, Ltd Wyomissing Pennsylvania 19610 —
VitaLink Research - Anderson Anderson South Carolina 29621 —
Medical University of South Carolina - PPDS Charleston South Carolina 29425 —
Clinical Research of Charleston Mt. Pleasant South Carolina 29464 —
Clinical Research of Rock Hill Rock Hill South Carolina 29732 —
VitaLink Research - Spartanburg Spartanburg South Carolina 29303 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
University of Texas Health Science Center at Tyler Tyler Texas 75708 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03320070, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 27, 2023 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03320070 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →